REPRESENTATIVES SWALWELL AND CRENSHAW INTRODUCE BIPARTISAN LEGISLATION TO PREVENT ADVERSE DRUG EFFECTS
March 30, 2024
March 30, 2024
WASHINGTON, March 30 -- Rep. Eric Swalwell, D-California, issued the following news release on March 29, 2024:
Today, U.S. Representatives Eric Swalwell (CA-14) and Dan Crenshaw (TX-02), introduced bipartisan legislation to better address drug-gene interactions to ensure that all Americans have access to treatment personalized to their needs.
The Right Drug Dose Now Act will enable the use of evidence-based pharmacogenomic (PGx) testing to prevent adverse drug events an . . .
Today, U.S. Representatives Eric Swalwell (CA-14) and Dan Crenshaw (TX-02), introduced bipartisan legislation to better address drug-gene interactions to ensure that all Americans have access to treatment personalized to their needs.
The Right Drug Dose Now Act will enable the use of evidence-based pharmacogenomic (PGx) testing to prevent adverse drug events an . . .